Skip to main content
Fig. 1 | Annals of Clinical Microbiology and Antimicrobials

Fig. 1

From: Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis–HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week

Fig. 1

Lopinavir (LPV) and ritonavir plasma concentrations and area under the plasma concentration–time curve (AUC) in HIV-1-infected patients who used combination lopinavir/ritonavir twice daily with rifabutin 150 mg three times per week or rifabutin 300 mg three times per week. Data are presented as the medians with the inter quartile range. RBT rifabutin, TPW three times per week, LPV/RTV lopinavir/ritonavir, IQR interquartile range, AUC0–12h area under the plasma concentration–time curve within the time span t0 to t12

Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us